Selwyn Vickers: Moved by the passion and expertise of the Olayan CCV team
Selwyn Vickers, President and CEO of Memorial Sloan Kettering Cancer Center, posted on LinkedIn:
“I am moved by the passion and expertise of the remarkable team at the Olayan Center for Cancer Vaccines (Olayan CCV) and was excited to celebrate their continued work at the Olayan CCV Open House.
The standing room-only event brought together cancer vaccine leaders at Memorial Sloan Kettering Cancer Center (MSK) to discuss their pioneering precision cancer vaccine solutions, which have shown great promise in stopping tumors from growing or spreading, eradicating cancer cells that remain in the body, and preventing cancer recurrence.
I am confident that their work will have a profound impact on the lives of countless individuals affected by cancer. This is a truly exciting moment for the future of cancer care.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023